| Ms Sharman Tybring Moses, MS RN CS APRN | |
|
200 Ter Heun Dr, Gosnold Thorne Counseling Ctr, Falmouth, MA 02540 | |
| (508) 563-2262 | |
| (508) 563-2660 |
| Full Name | Ms Sharman Tybring Moses |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Adult |
| Location | 200 Ter Heun Dr, Falmouth, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407943061 | NPI | - | NPPES |
| 006404 | Other | MA | HPHC |
| 163695 | Other | MA | TUFTS HEALTH PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | 163695PC (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Sharman Tybring Moses, MS RN CS APRN 3 Colt Lane, Plymouth, MA 02360 Ph: (508) 833-2782 | Ms Sharman Tybring Moses, MS RN CS APRN 200 Ter Heun Dr, Gosnold Thorne Counseling Ctr, Falmouth, MA 02540 Ph: (508) 563-2262 |
News Archive
More and more mothers facing childbirth are asking for a cesarean. There are many reasons for this, ranging from the social and cultural to the personal, such as fear about the birth. A review article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztbl 112: 489-95) by two Munich gynecologists, Ioannis Mylonas and Klaus Friese, considers the risks and benefits of cesarean delivery on maternal request.
The biotech giant is expected to plead guilty in a New York federal court criminal case. Some reports suggest the charges relate to "misbranding" - which refers to the promotion of drugs for uses that have not gained the Food and Drug Administration's approval.
"A draft proposal in the Senate to overhaul the nation's health-care system would require most people to buy health insurance, authorize an expansion of Medicaid coverage and create consumer-owned cooperative plans instead of the government coverage that President Obama is seeking," the Washington Post reports.
Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced positive results from CMX001 Study 201, a Phase 2 study evaluating CMX001 for the prevention of cytomegalovirus (CMV) disease in hematopoietic stem cell transplant (HCT) recipients.
› Verified 1 days ago
Ms. Eunice S Lucas, RN/PC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 200 Ter Heun Dr, Falmouth, MA 02540 Phone: 508-540-6550 |